---
title: "Location 5"
date: 2020-06-20T12:48:18-07:00
draft: true
layout: grcpage
name: John Doe
position: Titles and Position
---

My major research efforts currently are, a) defining mechanisms of stromal/epithelial-immune cell cross talk in IBD, b) defining components of treatment refractory (specifically, non-response to pro-inflammatory cytokine blockade) IBD at the cellular and tissue level, and c) predicting differences in clinical outcomes of interest across IBD clinical subtypes and populations, d) exploring the role of rare, IBD-associated variants of high effects, e) organizing large datasets for NIDDK IBDGC and IIBDGC, and f) developing select treatment targets based on IBD genetic and single cell expression findings. Since 2015, I have served as the Director for Personalized Medicine Institute at Mount Sinai. I am extremely excited by the explosion of data and new data tools that are accelerating collaborative efforts to benefit patients through genetic and genomic studies; I am eager to continue applying new data-approaches to benefit the NIDDK IBDGC.

[Mount Sinai Profile](https;//) 

##### Co-investigators:
Bruce Sands, MD, Chief, Gastroenterology Division.
Miriam Merad MD, PhD, Director, Immunology Institute
Ephraim Kenigsberg, PhD, Ke Hao PhD

##### GRC Abstract:
This application from the Mount Sinai Health System proposes participation as a genetic research center (GRC) within the NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC). IBD genetic discovery has disproportionately focused on European ancestry cohorts, despite high and rising prevalence in all US populations. In Aim 1, participation as a multi-disciplinary GRC in Consortium-wide projects is proposed. Expanding sequence and genotype data on non-European ancestry cohorts is proposed. New analytic methodologies have been developed whereby more ancestrally complex populations, such as Hispanic cohorts, can not only be meaningfully analyzed, but may confer substantial benefits in unlocking the overall genetic architecture of polygenic diseases, such as IBD. The application of novel clinical research tools involving efficient electronic health record and development of more objective endpoints can deepen longitudinal phenotype data for already recruited patients. Given the continued centrality of anti-TNF therapies in an era of multiple new therapies, studies to examine anti-TNF non-response (ileal resection, surgical specimens) and response (new anti-TNF initiation, endoscopically-based) are proposed. Specifically, in Aim 2, definition of intestinal single-cell expression features with anti-TNF non-response and response is proposed using mass cytometry protein analyses (Cytof), and single cell mRNA sequencing. Single cell analyses in IBD tissues shows enormous promise in systematically explicating the precise contributions in the most relevant context of the over 200 genome-wide significant IBD associations. Early single cell analyses point to a highly complex innate immune cell architecture, which may be distinct between various high effect IBD-associated risk alleles of innate immunity. Scaling key results through correlative techniques feasible in larger cohorts, such as using paraffin-embedded tissues and peripheral blood samples is proposed. The advent of multiple new therapies makes this a particularly propitious time to protocolize clinical practice, both to improve patient care, as well as to mine biosamples for IBD research. The insight that is gained through these studies can prioritize genes, cells and pathways from which to scale key results and protocols across the NIDDK IBDGC. The long-term goal of these studies is to efficiently develop protocols to most effectively treat IBD patients, catalyzing the advent of Precision IBD. Ancillary R01 liaison: Yuval Itan, PhD

##### Interests of the Mount Sinai GRC group beyond the GRC abstract
* Role of innate immune cell differentiation 
* Enteroids and reactive oxygen species 
* Role of GPCRs in IBD
* Comparative single cell analyses between European vs. African-American individuals 
* (Collaborative) Natural language processing and machine learning image analyses of hard outcome measures (endoscopy, pathology, radiology) of IBD

##### Selected publications
Martin JC, Chang C, Boschetti G, Ungaro R, Giri M, Grout JA, Gettler K, Chuang LS, Nayar S, Greenstein AJ, Dubinsky M, Walker L, Leader A, Fine JS, Whitehurst CE, Mbow ML, Kugathasan S, Denson LA, Hyams JS, Friedman JR, Desai PT, Ko HM, Laface I, Akturk G, Schadt EE, Salmon H, Gnjatic S, Rahman AH, Merad M*, Cho JH*, Kenigsberg E*. *, equal contributions. Single-cell analysis of Crohn’s disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy. Cell 2019; 1493. Chuang LS, Morrison J, Hsu NY, Labrias P, Nayar S, Chen E, Villaverde N, Facey JA, Boschetti G, Giri M, Castillo-Martin M, Thin TH, Sharma Y, Chu J, Cho JH. Zebrafish modeling of intestinal injury, bacterial exposures and medications defines epithelial in vivo responses relevant to human inflammatory bowel disease. Disease Models and Mechanisms August 13, 2019 Somineni HK, Venkateswaran S, Kilaru V, Marigorta UM, Mo A, Okou DT, Kellermayer R, Mondal K, Cobb D, Walters TD, Griffiths A, Noe JD, Crandall WV, Rosh JR, Mack DR, Heyman MB, Baker SS, Stephens MC, Baldassano RN, Markowitz JF, Dubinsky MC, Cho J, Hyams JS, Denson LA, Gibson G, Cutler DJ, Conneely KN, Smith AK, Kugathasan S. Blood-Derived DNA Methylation Signatures of Crohn Disease and Severity of Intestinal Inflammation. Gastroenterology. 2019 Feb 16.
        Contijoch EJ, Britton GJ, Yang C, Mogno I, Li Z, Ng R, Llewellyn SR, Hira S, Johnson C, Rabinowitz KM, Barkan R, Dotan I, Hirten RP, Fu SC, Luo Y, Yang N, Luong T, Labrias PR, Lira S, Peter I, Grinspan A, Clemente JC, Kosoy R, Kim-Schulze S, Qin X, Castillo A, Hurley A, Atreja A, Rogers J, Fasihuddin F, Saliaj M, Nolan A, Reyes-Mercedes P, Rodriguez C, Aly S, Santa-Cruz K, Peters L, Suárez-Fariñas M, Huang R, Hao K, Zhu J, Zhang B, Losic B, Irizar H, Song WM, Di Narzo A, Wang W, Cohen BL, DiMaio C, Greenwald D, Itzkowitz S, Lucas A, Marion J, Maser E, Ungaro R, Naymagon S, Novak J, Shah B, Ullman T, Rubin P, George J, Legnani P, Telesco SE, Friedman JR, Brodmerkel C, Plevy S, Cho JH, Colombel JF, Schadt EE, Argmann C, Dubinsky M, Kasarskis A, Sands B, Faith JJ. Gut microbiota density influences host physiology and is shaped by host and microbial factors. Elife. 2019 Jan 22;8. pii: e40553. doi: 10.7554/eLife.40553.
        Gettler K, Giri M, Kenigsberg E, Martin J, Chuang LS, Hsu NY, Denson LA, Hyams JS, Griffiths A, Noe JD, Crandall WV, Mack DR, Kellermayer R, Abraham C, Hoffman G, Kugathasan S, Cho JH. Prioritizing Crohn’s disease genes by integrating association signals with gene expression implicates monocyte subsets. Genes Immun 2019 Jan 29.
        Rivas, MA, Avila BE, Koskela J, Huang H, Stevens C, Pirnen M, Haritunians T, Neale BM, Kurki M, Ganna A, Schiff E, Pontikos N, Weisburd B, Lek M, Karczewski KJ, Bloom J, Minikel EV, Petersen BS, Beaugerie L, Seksik P, Cosnes C, Schreiber S, Bokemeyer B, Bethke J, International IBD Genetics Consortium, NIDDK IBD Genetics Consoritum, T2D-GENES Consortium, Heap G, Ahmad T, Plagnol V, Segal AW, Targan S, Turner D, Saavalainen P, Farkkila M, Kontula K, Palotie A, Brant SR, Duerr RH, Silverberg MS, Rioux JD, Weersma RK, Franke A, Jostins L, Anderson CA, Barrett JC, MacArthur DG, Jalas C, Sokol H, Xavier RJ, Pulver A, *Cho JH, *McGovern DPB, *Daly MJ. *corresponding authors. Insights​ ​into​ ​the​ ​genetic​ ​epidemiology​ ​of​ ​Crohn’s​ ​and​ ​rare​ ​diseases​ ​in​ ​the​ ​Ashkenazi​ ​Jewish population. In press, Plos Genetics 2018, e1007329
        Hui KY, Fernandez-Hernandez H, Hu J, Schaffner A, Pankratz N, Hsu NY, Chuang LS, Carmi S, Villaverde N, Li X, Rivas M, Levine AP, Bao X, Labrias PR, Haritunians T, Ruane D, Gettler K, Chen E, Li D, Schiff ER, Pontikos N, Barzilai N, Brant SR, Bressman S, Cheifetz AS, Clark LN, Daly MJ, Desnick RJ, Duerr RH, Katz S, Lencz T, Myers RH, Ostrer H, Ozelius L, Payami H, Peter Y, Rioux JD, Segal AW, Scott WK, Silverberg MS, Vance JM, Ubarretxena-Belandia I, Foroud T, Atzmon G, Pe’er I, Ioannou Y, McGovern DPB, Yue Z, Schadt EE, Cho JH*, Peter I*. *indicates equal contributions. Functional Variants in LRRK2 Confer Pleiotropic Effects on Crohn’s Disease and Parkinson’s Disease Risk. Science Translational Medicine 2018 eaai7795
        Huang H, Fang M, Jostins L, Mirkov MU, Boucher G, Anderson CA, Andersen V, Cleynen I, Cortes A, Crins F, D'Amato M, Deffontaine V, Dimitrieva J, Docampo E, Mahmoud Elansary M, Farh KK, Franke A, Gori AS, Goyette P, Halfvarson J, Haritunians T, Knight J, Lawrance IC, Lees CW, Louis E, Mariman R, Theo Meuwissen T, Myriam Mni M, Momozaws Y, Parkes M, Spain SL, Théâtre E, Trynka G, Satsangi J, Sommeren SV, Vermeire S, Xavier RJ, International IBD Genetics Consortium, Weersms RK, Duerr RH, Mathew CG, Rioux JD, McGovern DPB, Cho JH, Georges M, Daly MJ, Barrett JC. Association mapping of inflammatory bowel disease loci to single variant resolution. Nature 2017; 547: 173-178
        Cummings RJ, Barbet G, Bongers G, Hartmann BM, Gettler K, Muniz L, Furtado GC, Cho J, Lira SA, Blander JM. Different phagocytes sample apoptotic cells in situ to orchestrate distinct programs of tissue homeostasis. Nature 2016; 539: 565-569
        Li D, Achkar JP, Haritunians T, Jacobs JP, Hui KY, D’Amato M, Brand S, Radford-Smith G, Halfvarson J, Niess JH, Kugathasan S, Buning C, Schumm LP, Klei L, Anathakrishnan A, Aumais G, Baidoo L, Dubinsky M, Fiocchi C, Glas J, Milgrom R, Proctor DD, Regueiro M, Simms LA, Stempak JM, Targan SR, Torkvist L, Sharma Y, Devlin B, Borneman J, Hakonarson H, Xavier RJ, Daly M, Brant SR, Rioux JD, Silverberg MS, Cho JH, Braun J, McGovern DPB, Duerr RH. A pleiotropic missense variant in SLC39A8 is associated with Crohn’s disease and human gut microbiome composition. Gastroenterology 2016; 724-32.
        Chuang LS, Villaverde N, Hui KY, Mortha A, Rahman A, Levine  AP, Haritunians T, Sok Meng Ng SME, Zhang W, Hsu NY, Facey JA, Luong T, Fernandez-Hernandez H, Li D, Rivas M, Schiff ER, Gusev A, Schumm LP, Bowen BM, Sharma Y, Ning K, Remark R, Gnjatic S, Legnani P, George J, Sands BE, Stempak JM, Datta LW, Lipka S, Katz S, Cheifetz AS, Barzilai N, Pontikos N, Abraham C, Dubinsky M, Targan S, Taylor K, Rotter JI, Scherl EJ, Desnick RJ, Abreu MT, Zhao H, Atzmon G, Pe’er I, Kugathasan S, Hakonarson H, McCauley JL, Lencz T, Darvasi A, Plagnol V, Silverberg MS, Muise AM, Brant SR, Daly MJ, Segal AW, Duerr RH, Merad M, McGovern DPB, Peter I, Cho JH.  A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GMCSF. Gastroenterology 2016; 151: 710-723.
        Parian A, Limketkai B, Koh J, Brant SR, Bitton A, Cho JH, Duerr RH, McGovern DP, Proctor DD, Regueiro MD, Rioux JD, Schumm P, Taylor KD, Silverberg MS, Steinhart AH, Hernaez R, Lazarev M. Appendectomy does not decrease the risk of future colectomy in UC: results from a large cohort and meta-analysis. e-published Gut. 2016 Apr 13.
        Cleynen I, Boucher G, Jostins L, Schumm LP, Zeissig S, Ahmad T, Andersen V, Andrews JM, Annese V, Brand S, Brant SR, Cho JH, Daly MJ, Dubinsky M, Duerr RH, Ferguson LR, Franke A, Gearry RB, Goyette P, Hakonarson H, Halfvarson J, Hov JR, Huang H, Kennedy NA, Kupcinskas L, Lawrance IC, Lee JC, Satsangi J, Schreiber S, Théâtre E, van der Meulen-de Jong AE, Weersma RK, Wilson DC; International Inflammatory Bowel Disease Genetics Consortium, Parkes M, Vermeire S, Rioux JD, Mansfield J, Silverberg MS, Radford-Smith G, McGovern DP, Barrett JC, Lees CW. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study. Lancet. 2016; 387:156-67.
        Huang C, Haritunians T, Okou DT, Cutler DJ,  Zwick ME, Taylor KD, Alexander DST, Baldassano RN, Cross RK, Dassopoulos T, Dhere TA, Duerr RH, Hanson JS, Hou JK, Hussain SZ, Isaacs KL, Kachelries KE, Kader H, Kappelman MD, Katz J, Kellermayer R, Kirschner BS, Kuemmerle JF, Kumar A, Kwon JH, Lazarev M, Manno P, Moulton DE, Osuntokun BO, Patel A, Rioux JD, Rotter JI, Saeed S, Scherl EJ, Silverberg MS, Silverman A, Targan SR, Valentine J, Wang M, Simpson CL, Bridges SL, Kimberly RP, Rich SS, Cho JH, Di Rienzo A, Kao LWH, McGovern DPB, Brant SR, Kugathasan S. Identification of Major Genetic Susceptibility Loci for Inflammatory Bowel Disease in African Americans. Gastroenterology 2015; 149: 1575-86